Nasdaq
CLLS
Cellectis S.A.
- Health Care
- France
- Listed 2015
- 1 day
- −3.6%
- 1 month
- −16.5%
- 1 year
- −0.7%
$2.69 · Mkt cap $270M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Cellectis S.A.
$2.69 · Mkt cap $270M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Cellectis S.A. trades under the ticker CLLS on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2015. Its market capitalisation is $270M. The last closing price was $2.69, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −0.7%, and −16.5% over the past month. Returns are price returns and exclude dividends.
This page exists because CLLS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.